InMed Announces Results of 2025 Annual General and Special Meeting
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small...
Read moreInMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small...
Read moreIRIS Metals Limited (ASX: IR1, “IRIS” or “the Company”) is pleased to announce it has executed a binding Heads of...
Read moreUranium prices stayed fairly steady in 2025, but experts agree its long-term outlook is compelling, Demand picked up from reactor...
Read moreIn this video, Mary Ellen spotlights the areas driving market momentum following Taiwan Semiconductor’s record-breaking earnings report. She analyzes continued...
Read moreThe S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the...
Read more